Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 34, 2019 - Issue 1
Research Paper
In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts
, , 
, , , , , , , , , & show all
Marc Rolland de RavelINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; ;Centre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM, Centre Léon Bérard, Lyon, France; http://orcid.org/0000-0002-1642-9667View further author information
http://orcid.org/0000-0002-1642-9667View further author information, , Elisabeth MappusINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; http://orcid.org/0000-0003-0203-2746View further author information
http://orcid.org/0000-0003-0203-2746View further author information, , Luc RocheblaveINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; ;EA4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie-ISPB, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, Francehttp://orcid.org/0000-0002-3300-0416View further author information
http://orcid.org/0000-0002-3300-0416View further author information, Thierry LombergetINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; ;EA4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie-ISPB, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, Francehttp://orcid.org/0000-0002-4071-0002View further author information
http://orcid.org/0000-0002-4071-0002View further author information, Charles DumontetCentre de Recherche en Cancérologie de Lyon, Université Claude Bernard Lyon 1, INSERM, Centre Léon Bérard, Lyon, France; http://orcid.org/0000-0003-1875-134XView further author information
http://orcid.org/0000-0003-1875-134XView further author information, Marc Le BorgneEA4446 Bioactive Molecules and Medicinal Chemistry, Faculté de Pharmacie-ISPB, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, FranceCorrespondence[email protected]
http://orcid.org/0000-0003-1398-075XView further author information
http://orcid.org/0000-0003-1398-075XView further author information, , Catherine GrenotINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; http://orcid.org/0000-0002-7011-9002View further author information
http://orcid.org/0000-0002-7011-9002View further author information & Claude Y. CuilleronINSERM U863, Faculté de Pharmacie-ISPB, Université de Lyon, Université Lyon 1, Lyon, France; Correspondence[email protected]
http://orcid.org/0000-0001-8572-6334View further author information
http://orcid.org/0000-0001-8572-6334View further author information show allRelated Research Data
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators
Source:
Portland Press Ltd.
C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump.
Source:
American Chemical Society (ACS)
Photoaffinity Labeling of P-Glycoprotein
Source:
Bentham Science Publishers Ltd.
Multidrug resistance in cancer: role of ATP–dependent transporters
Source:
Springer Science and Business Media LLC
Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system.
Source:
Oxford University Press (OUP)
Tissue extraction procedures for investigation of urokinase plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in human breast carcinomas.
Source:
Springer Science and Business Media LLC
Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo.
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Identification of Clinically Used Drugs That Activate Pregnane X Receptors
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
RU49953: A non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance
Source:
Springer Science and Business Media LLC
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Source:
Elsevier BV
Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Source:
American Chemical Society (ACS)
Structure-activity relationship of natural and synthetic coumarins inhibiting the multidrug transporter P-glycoprotein.
Source:
Elsevier BV
Multidrug Resistance Reversal Agents
Source:
Wiley
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Source:
Elsevier BV
Expression of the PXR gene in various types of cancer and drug resistance.
Source:
Spandidos Publications
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Source:
Elsevier BV
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
Source:
Elsevier BV
Pregnane X Receptor and Cancer: Context-Specificity is Key.
Source:
KenzPub
Synthesis of New Steroidal Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance and Biological Evaluation on K562/R7 Erythroleukemia Cells
Source:
HAL CCSD
Linking provided by
